Home-based sleep monitoring using a novel non-contact, radar-based biomotion sensor in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor. [PDF]
Sleep BreathDietz-Terjung S +10 more
europepmc +1 more source
Impact of Elexacaftor-Tezacaftor-Ivacaftor on Gastrointestinal Symptoms, Intestinal Ultrasound, and Pancreatic Stiffness in Cystic Fibrosis. [PDF]
Clin Transl GastroenterolFraquelli M +5 more
europepmc +1 more source
Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis. [PDF]
Ther Adv Respir DisBlankenship S +6 more
europepmc +1 more source
Evaluation of Elexacaftor/Tezacaftor/Ivacaftor-Mediated Drug-Induced Liver Injury Using a Liver-On-Chip Model. [PDF]
Clin Transl SciShi A, Agarwal P, Liu ZX, Beringer PM.
europepmc +1 more source
Effects of cAMP and CFTR modulation on apical fluid pH in human airway Calu-3 cells. [PDF]
Physiol RepNguyen JP, Milad N, Hirota JA.
europepmc +1 more source
Understanding beliefs about elexacaftor-tezacaftor-ivacaftor therapy in adults living with cystic fibrosis. [PDF]
BMJ Open Respir ResO'Leary C +5 more
europepmc +1 more source
Expanding the Impact of New Cystic Fibrosis Therapies in Low- and Middle-Income Countries. [PDF]
Pediatr PulmonolKerem E.
europepmc +1 more source
Impact of COVID-19 and CFTR Modulators on Cystic Fibrosis: A Real-World Analysis of Care Patterns. [PDF]
Pediatr PulmonolHinton AC +3 more
europepmc +1 more source
Modelling the Repair of Carbon-Centered Protein Radicals by Phenolic Antioxidants. [PDF]
Antioxidants (Basel)Walton-Raaby M, Floen T, Mora-Diez N.
europepmc +1 more source